Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples